Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Oral Administration (Future) Amycretin Amycretin is being developed in both subcutaneous and oral formulations
Unlike single-target peptides, Cerebrolysin contains a balanced composition of low molecular weight neuropeptides (under 10,000 Da) and free amino acids that collectively mimic the biological functions of endogenous neurotrophic factors including brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), glial cell line-derived neurotrophic factor (GDNF), and ciliary neurotrophic factor (CNTF)
Because these injections are delivered into the muscle, they are absorbed more directly and predictably than oral supplements
Both compounds have substantial preclinical research records, with BPC-157 having a somewhat longer and broader body of published animal studies
As seen below, two of the peptides have been prohibited by the World Anti-Doping Agency
